To investigate whether HMMR mediates the influence of FIGNL1 on ECM-receptor interaction pathway remodeling, we used HepG2 human liver cancer cell line to knock down HMMR on the basis of FIGNL1 overexpression. This evidence concerns the gene HMMR and liver cancer.